Risk Factors for Gastrointestinal Complications During Glucocorticoid Therapy in Internal Medicine Inpatients: a Real-world Retrospective Analysis

Overview

Journal BMC Pharmacol Toxicol

Publisher Biomed Central

Specialty Pharmacology

Date 2025 Feb 20

PMID 39979942

Authors

Pengpeng Liu

Guangyao Li

Qinglin Yang

Kai Cao

Jiawei Wang

Affiliations

Soon will be listed here.

Abstract

Background: The risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients are rarely reported. This study aimed to investigate the risk factors for gastrointestinal complications in internal medicine patients using glucocorticoids.

Methods: Internal medicine inpatients receiving glucocorticoid therapy from February 2023 to September 2023 were included. Gastrointestinal complications were identified by careful review of the electronic medical records of these patients. The risk factors for gastrointestinal complications during glucocorticoid therapy were analyzed by univariable and multivariable logistic regression. Receiver operating characteristic (ROC) curve with Youden's index was used to determine the best cutoff point of the identified continuous variables.

Results: Of the 960 inpatients included, 88 had gastrointestinal complications, with the most common complications including 27 (30.7%) with abdominal discomfort, 26 (29.5%) with acid regurgitation and heartburn, and 14 (15.9%) with asymptomatic positive fecal occult blood. Multiple logistic regression analysis showed that age ≥ 65 years [OR = 2.014, 95% CI (1.096, 3.703), p = 0.024], history of gastroesophageal reflux disease (GERD) [OR = 1.810, 95% CI (1.009, 3.250), p = 0.047], history of peptic ulcer (PU) [OR = 5.636, 95% CI (1.505, 21.102), p = 0.010], maximum dose of glucocorticoids [OR = 1.003, 95% CI (1.001, 1.004), p = 0.001], and nonsteroidal anti-inflammatory drugs (NSAIDs) [OR = 2.788, 95% CI (1.023, 7.597), p = 0.045] were associated with more gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients. ROC curve analysis revealed that when the maximum dose of glucocorticoids was greater than 160 mg, gastrointestinal complications were more likely to occur.

Conclusions: The study shows that age ≥ 65 years, history of GERD, history of PU, maximum dose of glucocorticoids, and NSAIDs are associated with more gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients. Multidisciplinary teams, including physicians, pharmacists, and nurses, should consider increased monitoring to inpatients with high-risk factors.

References

Alderson P, Roberts I . Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005; (1):CD000196. PMC: 7043302. DOI: 10.1002/14651858.CD000196.pub2. View

Holt A, Blanche P, Zareini B, Rasmussen P, Strange J, Rajan D . Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants. Heart. 2021; 108(8):626-632. DOI: 10.1136/heartjnl-2021-319503. View

Vandewalle J, Luypaert A, De Bosscher K, Libert C . Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. 2017; 29(1):42-54. DOI: 10.1016/j.tem.2017.10.010. View

Whittemore J, Mooney A, Price J, Thomason J . Clinical, clinicopathologic, and gastrointestinal changes from aspirin, prednisone, or combination treatment in healthy research dogs: A double-blind randomized trial. J Vet Intern Med. 2019; 33(5):1977-1987. PMC: 6766539. DOI: 10.1111/jvim.15577. View

Nielsen G, Sorensen H, Mellemkjoer L, Blot W, McLaughlin J, Olsen J . Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med. 2001; 111(7):541-5. DOI: 10.1016/s0002-9343(01)00941-x. View

Desai J, Kolb J, Weitz J, Aisenberg J . Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies. Thromb Haemost. 2013; 110(2):205-12. DOI: 10.1160/TH13-02-0150. View

Hernandez-Diaz S, Rodriguez L . Steroids and risk of upper gastrointestinal complications. Am J Epidemiol. 2001; 153(11):1089-93. DOI: 10.1093/aje/153.11.1089. View

Vaduganathan M, Bhatt D . Gastrointestinal Bleeding With Oral Anticoagulation: Understanding the Scope of the Problem. Clin Gastroenterol Hepatol. 2017; 15(5):691-693. DOI: 10.1016/j.cgh.2016.12.033. View

CONN H, Poynard T . Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994; 236(6):619-32. DOI: 10.1111/j.1365-2796.1994.tb00855.x. View

10.

Gallant C, Kenny P . Oral glucocorticoids and their complications. A review. J Am Acad Dermatol. 1986; 14(2 Pt 1):161-77. DOI: 10.1016/s0190-9622(86)70018-2. View

11.

Sundahl N, Bridelance J, Libert C, De Bosscher K, Beck I . Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds. Pharmacol Ther. 2015; 152:28-41. DOI: 10.1016/j.pharmthera.2015.05.001. View

12.

Sostres C, Lanas A . Gastrointestinal effects of aspirin. Nat Rev Gastroenterol Hepatol. 2011; 8(7):385-94. DOI: 10.1038/nrgastro.2011.97. View

13.

Schacke H, Docke W, Asadullah K . Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96(1):23-43. DOI: 10.1016/s0163-7258(02)00297-8. View

14.

Liu P, Li G, Han M, Zhang C . Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China. BMC Pharmacol Toxicol. 2021; 22(1):65. PMC: 8547903. DOI: 10.1186/s40360-021-00530-w. View

15.

Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster C . Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016; 15(4):457-65. DOI: 10.1517/14740338.2016.1140743. View

16.

Lin C, Hu H, Luo J, Peng Y, Hou M, Lin H . Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther. 2013; 38(9):1119-28. DOI: 10.1111/apt.12483. View

17.

Piper J, Ray W, Daugherty J, Griffin M . Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991; 114(9):735-40. DOI: 10.7326/0003-4819-114-9-735. View

18.

Brouwer M, McIntyre P, Prasad K, van de Beek D . Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015; (9):CD004405. PMC: 6491272. DOI: 10.1002/14651858.CD004405.pub5. View

19.

Messer J, Reitman D, Sacks H, SMITH Jr H, CHALMERS T . Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1983; 309(1):21-4. DOI: 10.1056/NEJM198307073090105. View

20.

Carson J, Strom B, Schinnar R, Duff A, Sim E . The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med. 1991; 91(3):223-8. DOI: 10.1016/0002-9343(91)90119-i. View